Fairmount Funds Management LLC - Nov 24, 2023 Form 4 Insider Report for Spyre Therapeutics, Inc. (AGLE)

Signature
/s/ Tomas Kiselak, Managing Member of Fairmount Funds Management LLC
Stock symbol
AGLE
Transactions as of
Nov 24, 2023
Transactions value $
$0
Form type
4
Date filed
11/28/2023, 04:05 PM
Previous filing
Nov 1, 2023
Next filing
Dec 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGLE Common Stock Conversion of derivative security $0 +3.44M $0.00 3.44M Nov 24, 2023 By Fairmount Healthcare Co-Invest L.P. F1, F2
holding AGLE Common Stock 11K Nov 24, 2023 By Fairmount Healthcare Fund L.P. F2
holding AGLE Common Stock 367K Nov 24, 2023 By Fairmount Healthcare Fund II L.P. F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGLE Series A Preferred Stock Conversion of derivative security $0 -85.9K -100% $0.00* 0 Nov 24, 2023 Common Stock 3.44M By Fairmount Healthcare Co-Invest L.P. F1, F2
holding AGLE Series A Preferred Stock 12.7K Nov 24, 2023 Common Stock 507K By Fairmount Healthcare Fund L.P. F1, F2
holding AGLE Series A Preferred Stock 424K Nov 24, 2023 Common Stock 17M By Fairmount Healthcare Fund II L.P. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Following stockholder approval of the conversion of Series A preferred stock into shares of common stock, each share of Series A preferred stock automatically converted on November 24, 2023 into 40 shares of common stock, subject to certain beneficial ownership limitations.
F2 Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund L.P., Fairmount Healthcare Fund II L.P. and Fairmount Healthcare Co-Invest L.P. The general partner of Fairmount is Fairmount Funds Management GP LLC ("Fairmount GP"), of which Peter Harwin and Tomas Kiselak are the managing members. Fairmount, Fairmount GP, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.

Remarks:

The Reporting Persons may each be deemed a director by deputization of Issuer by virtue of the fact that each of Peter Harwin and Tomas Kiselak serve on the board of directors of Issuer and are also each a Managing Member of Fairmount Funds Management LLC.